# FDA 483 - Tuscano and Delucia Group DBA Entropic Labs - September 26, 2019

Source: https://www.keypedia.com/records/483/tuscano-and-delucia-group-dba-entropic-labs/cb528d5b-241e-45fe-93b4-c8ffa5594787

> FDA 483 for Tuscano and Delucia Group DBA Entropic Labs on September 26, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Tuscano and Delucia Group DBA Entropic Labs
- Inspection Date: 2019-09-26
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Tuscano and Delucia Group (DBA Entropic Labs) in Salt Lake City, UT, revealed severe deficiencies across its pharmaceutical and dietary supplement operations. The firm lacked fundamental quality control units, written procedures for complaint handling, master production records, laboratory controls, and stability testing programs. These widespread issues indicate a critical failure to adhere to good manufacturing practices, posing potential risks to product quality and consumer safety.

## Related Officers

- [Scott N. Lim](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)
- [Matthew A. Johnson](https://www.keypedia.com/people/matthew-a-johnson/e94e2d6a-1705-4ba4-b777-d514970e5371)

Company: https://www.keypedia.com/companies/tuscano-and-delucia-group-dba-entropic-labs/ab5697f5-6d3e-47be-9e5d-0e103a6b82f4

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face